WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China Emerges as Credible Challenger to US in ... (1/21/2026)

China Biopharma Innovation Takes Center Stage ... (1/17/2026)

China Biopharma Sees Record Financing and Lice... (1/13/2026)

China's 2025 Foreign Investment Catalogue Unlo... (1/13/2026)

China's Biopharma Sector Sets New Record for I... (1/12/2026)

China's Innovative Drug Licensing Deals Reach ... (1/12/2026)

Asia Emerges as the New Epicenter of Global Bi... (1/8/2026)

Chinese Drug Makers Hit Record US$136B in Glob... (1/8/2026)

China Biopharma Approvals Surge in December as... (1/6/2026)

China Vital to Insilico's Plan to Build Biotec... (1/4/2026)

China's Beautiful Biotech Chaos vs West's Eleg... (12/30/2025)

China Leads Globally in mRNA-Based Therapeutic... (12/27/2025)

Henlius Gains NMPA Green Light for Phase... (1/22/2026) China Companion Animal Health Market to ... (1/22/2026) Hua Medicine Targets Global Diabetes Gro... (1/22/2026) Corxel Raises Up to $287M to Push GLP-1 ... (1/22/2026) China Unveils New Policy to Transform Ph... (1/22/2026) CDE Seeks Public Input on Draft Guidance... (1/22/2026) NMPA Issues New Guidance to Standardize ... (1/22/2026) Bangshun Pharma Files for Hong Kong IPO (1/22/2026) Genmab Halts Development of Three China-... (1/22/2026) T-MAXIMUM Unveils First Human Data for C... (1/22/2026) Daiichi Sankyo Wins New China Approval f... (1/22/2026) AbbVie Secures China Approval for Skyriz... (1/22/2026) Juncell Unveils Phase I TIL Data for Adv... (1/22/2026) China Launches Clinical Trial of First A... (1/21/2026) Pomdoctor Deepens Pharma Partnerships to... (1/21/2026) CDE Issues Draft Guidance on Using Bayes... (1/21/2026) Roche Advances Oral GLP-1 Program as RO7... (1/21/2026) Pfizer Pulls Back on Mesothelin-Targetin... (1/21/2026)

China Companion Animal Health Market to Reach US$ 3.7B ... China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt...

Juncell Unveils Phase I TIL Data for Advanced NSCLC as ... T-MAXIMUM Unveils First Human Data for CRISPR-Edited CA... Bangshun Pharma Files for Hong Kong IPO Corxel Raises Up to $287M to Push GLP-1 Pill Toward Glo... Hua Medicine Targets Global Diabetes Growth with Non-GL...

NMPA Issues New Guidance to Standardize Vaccine Adjuvan... CDE Seeks Public Input on Draft Guidance for Risk Asses... China Unveils New Policy to Transform Pharmacies into C... CDE Issues Draft Guidance on Using Bayesian External Da... NMPA Announces Adoption of ICH Q8/Q9/Q10 Q&A (R5) Guide...

Pomdoctor Deepens Pharma Partnerships to Drive Internet... NHSA Seeks Feedback on Draft Guidelines for Real-World... China Expands Cross-Province Use of Employee BMI Funds ... China Rolls Out Smart Medical Insurance Payments to Imp... China Convenes National Health Work Conference to Outli...

China's Supreme Court Upholds Semaglutide Patent, Stren... BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

AbbVie Secures China Approval for Skyrizi in Ulcerative... Daiichi Sankyo Wins New China Approval for Enhertu Genmab Halts Development of Three China-Originated Onco... Henlius Gains NMPA Green Light for Phase 1b/2 Trial of ... Telix Advances China Strategy as Prostate Cancer Imagin...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves China Moves to Prosecute Former Traditional Medicine Re...

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...